Cargando…
Topical Tirbanibulin, a Dual Src Kinase and Tubulin Polymerization Inhibitor, for the Treatment of Plaque-Type Psoriasis: Phase I Results
Plaque-type psoriasis is a common skin disorder. Tirbanibulin (KX01) is a new Src kinase inhibitor with potent antiproliferative activity against keratinocytes and has been approved for treatment of actinic keratosis. This Phase I study investigates the safety and activity of KX01 ointment in patien...
Autores principales: | Hong, Jin-Bon, Wu, Po-Yuan, Qin, Albert, Huang, Yi-Wen, Tseng, Kuan-Chiao, Lai, Ching-Yu, Chan, Wing-Kai, Fang, Jane, Cutler, David L., Tsai, Tsen-Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608911/ https://www.ncbi.nlm.nih.gov/pubmed/36297594 http://dx.doi.org/10.3390/pharmaceutics14102159 |
Ejemplares similares
-
Tirbanibulin Attenuates Pulmonary Fibrosis by Modulating Src/STAT3 Signaling
por: Wang, Xin, et al.
Publicado: (2021) -
Topical tirbanibulin eradication of periungual squamous cell carcinoma
por: Moore, Angela Yen, et al.
Publicado: (2021) -
Contact Sensitization and Phototoxic and Photoallergic Potential of Tirbanibulin 1% Ointment in Healthy Volunteers
por: Dosik, Jonathan, et al.
Publicado: (2022) -
Rapid resolution of recalcitrant basal cell carcinoma of the ear with topical tirbanibulin
por: Moore, Angela, et al.
Publicado: (2022) -
Topical tirbanibulin resolves recalcitrant condyloma acuminata: Retrospective case series
por: Moore, Angela Yen, et al.
Publicado: (2023)